跳至主要内容
临床试验/IRCT20120707010203N11
IRCT20120707010203N11已完成2 期

Evaluation of spironolactone nanostructured lipid carriers coated with chitosan and clindamycin solution co-treatment effect on severity of mild to moderate acne vulgaris

Mazandaran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 years 至 no limit(—)
性别
All

入选标准

  • Patients with mild to moderate acne, defined as a score of 1 to 30 on the global acne grading system (GAGS) scale.
  • Patients which received no previous acne therapies participated in the study, or have not received any treatment before this study

排除标准

  • Patients which received topical anti-acne therapy two months before or during the study or any systemic therapy with antibiotics, OCP, retinoid, and spironolactone before or during the study
  • Patients were excluded if they had other disease;
  • Pregnant, or planning to become pregnant women

研究者

相似试验